Multimodality imaging approach to cardiac amyloidosis: part 2

Abstract With recent advances in cardiac imaging, genetics, and treatment options, cardiac amyloidosis (CA) is now recognized as an important and under diagnosed condition contributing to cardiovascular morbidity and mortality. Although still considered a rare disease, CA is now recognized as an imp...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Sennott, Jacqueline [verfasserIn]

Ananthasubramaniam, Karthikeyan

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2021

Schlagwörter:

Cardiac amyloidosis

Light chain cardiac amyloidosis

Transthyretin cardiac amyloidosis

Electrocardiogram

Echocardiogram

Cardiac magnetic resonance

Technetium-99 m pyrophosphate

Multimodality imaging

Anmerkung:

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021

Übergeordnetes Werk:

Enthalten in: Heart failure reviews - Dordrecht [u.a.] : Springer Science + Business Media B.V, 1996, 27(2021), 5 vom: 25. Okt., Seite 1515-1530

Übergeordnetes Werk:

volume:27 ; year:2021 ; number:5 ; day:25 ; month:10 ; pages:1515-1530

Links:

Volltext

DOI / URN:

10.1007/s10741-021-10179-6

Katalog-ID:

SPR047880600

Nicht das Richtige dabei?

Schreiben Sie uns!